genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
Synthetic Data for a Real Pandemic
Gene Therapy
Bayer Approach to Partnerships, Pipelines, and Platforms
Genomics
Genomics in the Clinic: A Candid Conversation with Sema4 CEO Eric…
Circulating Tumor Cell
Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform
Biomarkers
Guardant Health Launches Early-Stage Colorectal Cancer ctDNA Assay
News
Cancer
Bioenergetic Mechanism for Signal Regulation May Explain Cancer’s Warburg Effect
Cannabinoids
Cannabidiol’s Antibiotic Potential Extends to Gram-Negative Bacteria
Neuroscience
Dopamine Circuit Responsible for Temporary Memory Loss
OMICs
Skin Cell Atlas Uncovers Origin of Inflammatory Skin Disease
Animal Models
CRISPR-Based Cancer Cell Lineage Tracing Offers Insights into Drivers of Metastasis
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
Biopharma Manufacturers Shouldn’t Rush When “Going Digital”
Bioprocessing
Separating Cells with Microfluidics
Trends for 2021
Beyond 2021: Cell Therapy Manufacturing Trends
Bioprocessing
Machine Learning for Better Bioprocess Data Analysis
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Cancer
Bioenergetic Mechanism for Signal Regulation May Explain Cancer’s Warburg Effect
Cannabinoids
Cannabidiol’s Antibiotic Potential Extends to Gram-Negative Bacteria
OMICs
Skin Cell Atlas Uncovers Origin of Inflammatory Skin Disease
Animal Models
CRISPR-Based Cancer Cell Lineage Tracing Offers Insights into Drivers of Metastasis
Magazine
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
January 2021 Vol. 41 No. 1
Leroy Hood: Reflections on a Legendary Career
January 2021 Vol. 41 No. 1
COVID-19 One Year Later: The Biology and the Business
Traditional Medicine
Monoclonal Antibodies: Developers Explore New Territories
Roundtable
Uncharted Territory: Top Challenges Facing Gene Therapy Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
AstraZeneca
AstraZeneca
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AstraZeneca
AstraZeneca to Acquire Alexion for $39B, Adding Rare Disease, Immunology Assets
AstraZeneca
AstraZeneca-Oxford COVID-19 Vaccine Shows Positive Phase II Results
AstraZeneca
U.S. Army Awards $599M in Contracts for AstraZeneca Vaccine, Lilly Antibody vs. COVID-19
AstraZeneca
AstraZeneca, J&J Resuming Phase III COVID-19 Vaccine Trials
AstraZeneca
COVID-19: AstraZeneca, U. of Oxford Resume Phase III Trial; Pfizer, BioNTech Eye 14,000 More Participants
AstraZeneca
AstraZeneca Pauses Phase III COVID-19 Vaccine Trial, Citing “Potentially Unexplained Illness”
AstraZeneca
As Pressure Mounts, CEOs Commit to Science, Safety in Developing COVID-19...
AstraZeneca
AstraZeneca Launches 30,000-Patient Phase III U.S. Trial of COVID-19 Vaccine
AstraZeneca
AstraZeneca, Daiichi Sankyo Target TROP2 in Up-to-$6B Cancer Collaboration
AstraZeneca
Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch
AstraZeneca
AstraZeneca, U. of Oxford Report Positive Phase I/II Data for COVID-19...
AstraZeneca
AstraZeneca Bolsters Manufacturing Capacity, Support for COVID-19 Vaccine
AstraZeneca
AstraZeneca, Accent Launch up to $1.1B+ Cancer Collaboration Targeting RNA-Modifying Proteins
AstraZeneca
AstraZeneca Joins U. of Oxford and Spinout to Develop COVID-19 Vaccine
AstraZeneca
Allergan Sells Zenpep, Brazikumab as Regulators Review AbbVie $63B Deal
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
